MedPath

Effect of Elliptical Training on Metabolic Homeostasis in Metabolic Syndrome

Not Applicable
Conditions
Metabolic Syndrome
Interventions
Behavioral: exercise training on elliptical device
Behavioral: group B (control group)
Registration Number
NCT04635202
Lead Sponsor
Cairo University
Brief Summary

The growing prevalence of metabolic syndrome (MetS) in the worldwide is becoming a serious health problem and economic burden. MetS has become a crucial risk factor for the development of type 2 diabetes mellitus (T2DM) and cardiovascular diseases (CVD). The rising rates of CVD and diabetes, which are the two leading causes of death. To prevent the progression of MetS to diabetes and CVD, regular physical activity is required.

Elliptical trainer device is a relatively new modality of exercise and is advertised to be superior to a treadmill because of the low joint impact and the more reasonable costs of an elliptical trainer compared to a treadmill. Additional quantitative research is needed to further evaluate the effectiveness of elliptical trainers and the physiological and perceptual responses to the machine.

Detailed Description

Forty sedentary MeTS patients (from both sexes) will be randomly divided to group A and group B.

-Group A (Elliptical training group): This group (n=20) will receive aerobic training on an elliptical trainer for 16 weeks (3 sessions per week). The session will start with 5 minutes warming up at 50 % of maximal heart rate (MHR), 20-minute continuous ET at 70% of MHR, 12 minutes (4×3) intervals at 90% of MHR with a 3-minute active recovery at 70% of MHR between intervals, and finally 5-minute cool-down period at 50% of MHR.

Group B: this group will continue their normal daily physical activities without any additional training

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • The MeTS subjects who will have three or more of the following criteria: 1) waist circumference more than 102 cm, triglycerides more than 150 mg/dL, 3) blood pressure (BP) more than 130/85 mmHg, 4) high-density lipoprotein (HDL) less than 40 mg/dL, .

Exclusion criteria:

  • Renal, pulmonary, cardiac, vascular, respiratory, hepatic, autoimmune disorders.
  • Smoker, addictive, cancer, and alcoholic patients.
  • Lower limb arthritis or any orthopaedic problem will hinder the training.
  • Participation in any type of sport training in the previous 6 months.
  • Pregnant or lactating women.
  • Patients with thyroid gland dysfunction.
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
group Aexercise training on elliptical devicepatients (n=30) in this group will receive 16 weeks of elliptical training on elliptical trainer, 3 times per week. the training will start with 5 minutes warming up at 50 % of maximal heart rate (MHR), 20-minute continuous ET at 70% of MHR, 12 minutes (4×3) intervals at 90% of MHR with a 3-minute active recovery at 70% of MHR between intervals, and finally 5-minute cool-down period at 50% of MHR
Group B (control group)group B (control group)patients (n=30) in this group will receive general advises on maintaining physical activities
Primary Outcome Measures
NameTimeMethod
TriglyceridesIt will be measured after 16 weeks of training

Triglycerides is one of lipid profile indicators

high density lipoproteinIt will be measured after 16 weeks of training

high density lipoprotein is one of lipid profile indicators

Secondary Outcome Measures
NameTimeMethod
Fasting blood glucoseIt will be measured after 16 weeks of training

It will be measured via a blood glucose meter

InsulinIt will be measured after 16 weeks of training

it will be measured via a blood sample

The HOMA-IR (Homeostatic Model Assessment for Insulin ResistanceIt will be measured after 16 weeks of training

HOMA-IR = \[fasting insulin (μU/mL)

× fasting glucose (mmol)\]/22.5

Waist circumferenceIt will be measured after 16 weeks of training

it will be measured by inelastic tape at the umbilicus level

weightIt will be measured after 16 weeks of training

the weight scale will be used

Leg strength testIt will be measured after 16 weeks of training

will be assessd by leg dynamometer

Systolic blood pressureIt will be measured after 16 weeks of training

It will be measured via Sphygmomanometer

diastolic blood pressureIt will be measured after 16 weeks of training

It will be measured via Sphygmomanometer

% body fatIt will be measured after 16 weeks of training

percentage of body fat composition

Trial Locations

Locations (1)

Faculty of Physical Therapy Cairo University

🇪🇬

Giza, Dokki, Egypt

© Copyright 2025. All Rights Reserved by MedPath